Anuncio • May 02
Fuchs SE Reaffirms Earnings Guidance for the Year 2025 Fuchs SE reaffirmed earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million. Anuncio • Mar 27
Fuchs SE, Annual General Meeting, May 07, 2025 Fuchs SE, Annual General Meeting, May 07, 2025, at 10:00 W. Europe Standard Time. Anuncio • Mar 23
Fuchs SE Proposes Dividend for the Year 2024 Fuchs SE proposed to the annual general meeting a dividend increase by 5%, to EUR 1.16 (EUR 1.10) per ordinary share for the year 2024. Anuncio • Mar 22
Fuchs SE Provides Earnings Guidance for the Year 2025 Fuchs SE provided earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million. Reported Earnings • Nov 01
Third quarter 2024 earnings: Revenues exceed analyst expectations Third quarter 2024 results: Revenue: €902.0m (up 3.0% from 3Q 2023). Net income: €80.0m (up 3.9% from 3Q 2023). Profit margin: 8.9% (up from 8.8% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Anuncio • Sep 13
Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag. Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag on September 13, 2024.
For the period ending December 31, 2023, Strub & Co. Ag reported total revenue of €15 million.
The transaction to be completed by the end of 2024. Anuncio • Aug 29
Fuchs SE to Report Fiscal Year 2024 Results on Mar 21, 2025 Fuchs SE announced that they will report fiscal year 2024 results on Mar 21, 2025 Reported Earnings • Aug 01
Second quarter 2024 earnings: EPS in line with expectations, revenues disappoint Second quarter 2024 results: EPS: €0.59 (up from €0.50 in 2Q 2023). Revenue: €887.0m (flat on 2Q 2023). Net income: €78.0m (up 15% from 2Q 2023). Profit margin: 8.8% (up from 7.7% in 2Q 2023). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Jul 26
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 16% to €37.02. The fair value is estimated to be €46.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.9% in 2 years. Earnings are forecast to grow by 20% in the next 2 years. Buy Or Sell Opportunity • Jul 26
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 16% to €37.02. The fair value is estimated to be €46.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.9% in 2 years. Earnings are forecast to grow by 20% in the next 2 years. Upcoming Dividend • May 02
Upcoming dividend of €1.11 per share Eligible shareholders must have bought the stock before 09 May 2024. Payment date: 13 May 2024. Payout ratio is a comfortable 53% and this is well supported by cash flows. Trailing yield: 2.5%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.0%). Reported Earnings • May 01
First quarter 2024 earnings released First quarter 2024 results: Revenue: €877.0m (down 6.3% from 1Q 2023). Net income: €77.0m (up 5.5% from 1Q 2023). Profit margin: 8.8% (up from 7.8% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany. Anuncio • Apr 24
Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe). Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe) on April 22, 2024. As of financial year 2023, Lubricant Consult reported a sales revenue of €40 million. The transaction is subject to approval from the cartel authorities and is expected to close in the third quarter of 2024. Declared Dividend • Mar 14
Dividend increased to €1.11 Dividend of €1.11 is 3.7% higher than last year. Ex-date: 9th May 2024 Payment date: 13th May 2024 Dividend yield will be 2.6%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (32% cash payout ratio). The dividend has increased by an average of 5.5% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 31% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Mar 13
Full year 2023 earnings released Full year 2023 results: Revenue: €3.54b (up 3.8% from FY 2022). Net income: €282.0m (up 8.9% from FY 2022). Profit margin: 8.0% (up from 7.6% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Anuncio • Dec 08
Fuchs SE Appoints Dr. Timo Reister as Deputy Chairman of the Executive Board The Supervisory Board of FUCHS SE has appointed Dr. Timo Reister (44) as Deputy Chairman of the Executive Board. The appointment will take effect from January 1, 2024 and is part of the company's long-term succession planning. Timo Reister joined FUCHS in 2009 after studying business administration and completing his doctorate and has been a member of the Executive Board based in Mannheim since 2016. After joining the company, he was responsible for the OEM and specialty business in the USA as well as for FUCHS Mexico for almost five years. He then moved to China in 2014, where he headed the Asia-Pacific region as a member of the Group Management Committee. Through these stays, Timo Reister got to know FUCHS' two most important foreign markets on the ground. At present, he is responsible for the two global regions Americas and Asia-Pacific as well as for three global sales divisions: OEM, Automotive Aftermarket and Mining. The responsibilities of the Executive Board remain unchanged by this appointment. In addition to Stefan FUCHS (55) and Dr. Timo Reister (44), the at the end of 2022 newly formed Executive Board team consists of Isabelle Adelt (39), CFO, Dr. Sebastian Heiner (45), CTO, and Dr. Ralph Rheinboldt responsible for the EMEA region (Europe, Africa and Middle East) and the Industry and Specialties divisions. Reported Earnings • Oct 28
Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Third quarter 2023 results: EPS: €0.57. Revenue: €876.0m (down 2.9% from 3Q 2022). Net income: €77.0m (up 10.0% from 3Q 2022). Profit margin: 8.8% (up from 7.8% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 10%. Earnings per share (EPS) exceeded analyst estimates by 7.9%. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Buying Opportunity • Oct 10
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 1.5%. The fair value is estimated to be €44.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 8.5%. Revenue is forecast to grow by 2.6% in 2 years. Earnings is forecast to grow by 19% in the next 2 years. Buying Opportunity • Sep 22
Now 21% undervalued Over the last 90 days, the stock is up 1.8%. The fair value is estimated to be €43.60, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 8.5%. Revenue is forecast to grow by 3.3% in 2 years. Earnings is forecast to grow by 19% in the next 2 years. Anuncio • Sep 12
Fuchs SE to Report Fiscal Year 2023 Results on Mar 12, 2024 Fuchs SE announced that they will report fiscal year 2023 results Pre-Market on Mar 12, 2024 Anuncio • Sep 05
Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda.. Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023.
Fuchs SE (XTRA:FPE3) completed the acquisition of the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023. Reported Earnings • Jul 30
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: €886.0m (up 6.5% from 2Q 2022). Net income: €68.0m (up 12% from 2Q 2022). Profit margin: 7.7% (up from 7.3% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 2.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Upcoming Dividend • Apr 27
Upcoming dividend of €1.07 per share at 2.9% yield Eligible shareholders must have bought the stock before 04 May 2023. Payment date: 08 May 2023. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.9%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.4%). Reported Earnings • Mar 09
Full year 2022 earnings released: EPS: €1.87 (vs €1.82 in FY 2021) Full year 2022 results: EPS: €1.87 (up from €1.82 in FY 2021). Revenue: €3.41b (up 19% from FY 2021). Net income: €259.0m (up 2.4% from FY 2021). Profit margin: 7.6% (down from 8.8% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 2.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 9% per year. Reported Earnings • Oct 30
Third quarter 2022 earnings released Third quarter 2022 results: Revenue: €902.0m (up 26% from 3Q 2021). Net income: €70.0m (up 15% from 3Q 2021). Profit margin: 7.8% (down from 8.5% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Anuncio • Oct 25
Fuchs Petrolub SE to Report Fiscal Year 2022 Results on Mar 08, 2023 Fuchs Petrolub SE announced that they will report fiscal year 2022 results on Mar 08, 2023 Reported Earnings • Aug 01
Second quarter 2022 earnings: Revenues in line with analyst expectations Second quarter 2022 results: Revenue: €832.0m (up 17% from 2Q 2021). Net income: €61.0m (down 6.2% from 2Q 2021). Profit margin: 7.3% (down from 9.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 4.7%, compared to a 5.9% growth forecast for the industry in Germany. Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €24.48, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 10x in the Chemicals industry in Germany. Total loss to shareholders of 24% over the past three years. Reported Earnings • May 01
First quarter 2022 earnings: Revenues exceed analyst expectations First quarter 2022 results: Revenue: €808.0m (up 16% from 1Q 2021). Net income: €67.0m (down 5.6% from 1Q 2021). Profit margin: 8.3% (down from 10% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.9%. Over the next year, revenue is forecast to grow 6.9%, compared to a 11% growth forecast for the industry in Germany. Upcoming Dividend • Apr 27
Upcoming dividend of €1.03 per share Eligible shareholders must have bought the stock before 04 May 2022. Payment date: 06 May 2022. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 3.4%. Lower than top quartile of German dividend payers (4.0%). Lower than average of industry peers (5.0%). Reported Earnings • Nov 03
Third quarter 2021 earnings released: EPS €0.44 The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: €718.0m (up 16% from 3Q 2020). Net income: €61.0m (down 3.2% from 3Q 2020). Profit margin: 8.5% (down from 10% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year and the company’s share price has also fallen by 1% per year. Reported Earnings • Aug 01
Second quarter 2021 earnings released The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €714.0m (up 42% from 2Q 2020). Net income: €65.0m (up 132% from 2Q 2020). Profit margin: 9.1% (up from 5.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 5% per year. Reported Earnings • May 04
First quarter 2021 earnings released The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €697.0m (up 13% from 1Q 2020). Net income: €71.0m (up 39% from 1Q 2020). Profit margin: 10% (up from 8.3% in 1Q 2020). The increase in margin was driven by higher revenue. Upcoming Dividend • Apr 28
Upcoming dividend of €0.99 per share Eligible shareholders must have bought the stock before 05 May 2021. Payment date: 07 May 2021. Trailing yield: 2.2%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.5%). Reported Earnings • Mar 10
Full year 2020 earnings released: EPS €1.58 (vs €1.64 in FY 2019) The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: €2.38b (down 7.5% from FY 2019). Net income: €220.0m (down 3.5% from FY 2019). Profit margin: 9.3% (up from 8.9% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Analyst Estimate Surprise Post Earnings • Mar 10
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 0.1%. Earnings per share (EPS) also surpassed analyst estimates by 7.1%. Over the next year, revenue is forecast to grow 8.6%, compared to a 5.7% growth forecast for the Chemicals industry in Germany. Is New 90 Day High Low • Feb 26
New 90-day low: €45.50 The company is down 5.0% from its price of €47.86 on 27 November 2020. The German market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €45.12 per share. Is New 90 Day High Low • Feb 08
New 90-day high: €49.40 The company is up 5.0% from its price of €46.88 on 10 November 2020. The German market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €46.57 per share. Is New 90 Day High Low • Nov 11
New 90-day high: €47.50 The company is up 24% from its price of €38.18 on 13 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €41.67 per share. Analyst Estimate Surprise Post Earnings • Nov 05
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 14%. Earnings per share (EPS) also surpassed analyst estimates by 38%. Over the next year, revenue is forecast to grow 4.2%, compared to a 2.7% growth forecast for the Chemicals industry in Germany. Is New 90 Day High Low • Oct 17
New 90-day high: €45.92 The company is up 21% from its price of €37.98 on 17 July 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €42.07 per share. Is New 90 Day High Low • Sep 29
New 90-day high: €42.40 The company is up 18% from its price of €35.90 on 01 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €41.25 per share.